Get the Stockscreener App
244.46
3.03%
-7.65
After Hours:
244.46
Overview
News
Price History
Option Chain
Financials
Why RMD Down?
Discussions
Forecast
Stock Split
Dividend History
Resmed Inc stock is traded at $244.46, with a volume of 1.01M.
It is down -3.03% in the last 24 hours and down -9.48% over the past month.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
See More
Previous Close:
$252.11
Open:
$250.04
24h Volume:
1.01M
Relative Volume:
0.96
Market Cap:
$35.79B
Revenue:
$5.26B
Net Income/Loss:
$1.44B
P/E Ratio:
25.02
EPS:
9.7713
Net Cash Flow:
$1.76B
1W Performance:
-2.80%
1M Performance:
-9.48%
6M Performance:
-1.02%
1Y Performance:
+5.63%
1-Day Range:
$244.29
$251.17
1-Week Range:
$244.29
$256.00
52-Week Range:
$199.92
$293.81
Resmed Inc Stock (RMD) Company Profile
Name
Resmed Inc
Sector
Industry
Phone
(858) 746-2400
Address
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Compare RMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Initiated | Citigroup | Buy |
| Sep-02-25 | Upgrade | CLSA | Hold → Outperform |
| Jul-15-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Mar-19-25 | Initiated | Morgan Stanley | Overweight |
| Jan-16-25 | Initiated | Goldman | Buy |
| Jan-10-25 | Initiated | Piper Sandler | Neutral |
| Dec-13-24 | Initiated | Stifel | Hold |
| Sep-24-24 | Initiated | Robert W. Baird | Outperform |
| Sep-18-24 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Sep-04-24 | Downgrade | Needham | Buy → Hold |
| Jun-25-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Jun-24-24 | Downgrade | Citigroup | Buy → Neutral |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Oct-27-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-12-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-09-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-29-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-06-23 | Upgrade | Needham | Hold → Buy |
| Sep-05-23 | Downgrade | UBS | Buy → Neutral |
| Aug-01-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-23-23 | Initiated | UBS | Buy |
| Apr-14-23 | Initiated | Mizuho | Buy |
| Jan-17-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-20-22 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Sep-08-22 | Upgrade | Citigroup | Neutral → Buy |
| Aug-15-22 | Downgrade | CLSA | Buy → Outperform |
| Aug-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Aug-12-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-12-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jun-06-22 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Jan-31-22 | Upgrade | Citigroup | Neutral → Buy |
| Jan-31-22 | Upgrade | Goldman | Neutral → Buy |
| Jan-28-22 | Upgrade | RBC Capital Mkts | Underperform → Sector Perform |
| Jan-24-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-24-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Jan-13-22 | Upgrade | CLSA | Outperform → Buy |
| Jan-13-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-21-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Dec-06-21 | Upgrade | Macquarie | Neutral → Outperform |
| Oct-22-21 | Upgrade | CLSA | Underperform → Outperform |
| Aug-02-21 | Downgrade | CLSA | Outperform → Sell |
| Aug-02-21 | Downgrade | Needham | Buy → Hold |
| Jul-28-21 | Upgrade | Jefferies | Underperform → Hold |
| Jul-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-14-21 | Initiated | RBC Capital Mkts | Underperform |
| Jun-28-21 | Downgrade | Citigroup | Buy → Neutral |
| Jun-22-21 | Upgrade | Macquarie | Neutral → Outperform |
| Jun-22-21 | Initiated | Robert W. Baird | Neutral |
| Jun-21-21 | Reiterated | Needham | Buy |
| Jun-16-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-09-21 | Upgrade | CLSA | Sell → Outperform |
| May-21-21 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-21 | Upgrade | Citigroup | Neutral → Buy |
| Apr-30-21 | Downgrade | Citigroup | Buy → Neutral |
| Mar-16-21 | Upgrade | Needham | Hold → Buy |
| Nov-02-20 | Upgrade | UBS | Neutral → Buy |
| Oct-30-20 | Upgrade | JP Morgan | Underweight → Neutral |
| Oct-27-20 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-07-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-17-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-01-20 | Downgrade | JP Morgan | Neutral → Underweight |
| May-01-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Feb-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-03-20 | Initiated | CLSA | Underperform |
| Jan-31-20 | Downgrade | UBS | Buy → Neutral |
| Jan-10-20 | Initiated | Oppenheimer | Perform |
| Nov-22-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-29-19 | Upgrade | UBS | Neutral → Buy |
| Jul-16-19 | Downgrade | UBS | Buy → Neutral |
| May-06-19 | Upgrade | UBS | Neutral → Buy |
| Apr-18-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-25-19 | Downgrade | Goldman | Buy → Neutral |
| Jan-25-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-26-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-02-18 | Initiated | Goldman | Buy |
View All
Resmed Inc Stock (RMD) Latest News
Key resistance and support levels for ResMed Inc.2025 EndofYear Setup & Free High Return Stock Watch Alerts - newser.com
Is ResMed Inc. (Common Stock) (RMEA) stock nearing a technical breakoutMarket Risk Analysis & Weekly High Potential Alerts - newser.com
ResMed Inc Updates Dividend Exchange Rate for CDI Holders - TipRanks
What makes ResMed Inc. stock appealing to growth investors2025 Geopolitical Influence & Consistent Growth Equity Picks - newser.com
Can swing trading help recover from ResMed Inc. lossesQuarterly Earnings Summary & Fast Momentum Entry Tips - newser.com
Will earnings trigger a reversal in ResMed Inc.Trade Signal Summary & Free Real-Time Market Sentiment Alerts - newser.com
Using RSI to spot recovery in ResMed Inc.2025 Historical Comparison & Growth Focused Investment Plans - newser.com
Why analysts remain bullish on ResMed Inc. stock2025 Pullback Review & Stock Portfolio Risk Management - newser.com
Will ResMed Inc. stock benefit from mergersDay Trade & Smart Allocation Stock Reports - newser.com
Vise Technologies Inc. Invests $553,000 in ResMed Inc. $RMD - MarketBeat
LGT Capital Partners LTD. Lowers Stock Holdings in ResMed Inc. $RMD - MarketBeat
Investing in ResMed (NYSE:RMD) five years ago would have delivered you a 21% gain - Yahoo Finance
Mitsubishi UFJ Trust & Banking Corp Has $19.76 Million Position in ResMed Inc. $RMD - MarketBeat
Police & Firemen s Retirement System of New Jersey Has $5.74 Million Holdings in ResMed Inc. $RMD - MarketBeat
KBC Group NV Buys 2,006 Shares of ResMed Inc. $RMD - MarketBeat
Will ResMed Inc. (RME) stock profit from automation waveJuly 2025 EndofMonth & Risk Adjusted Buy and Sell Alerts - newser.com
Banco Bilbao Vizcaya Argentaria S.A. Sells 1,381 Shares of ResMed Inc. $RMD - MarketBeat
Is ResMed Inc. stock positioned for digital growth eraJuly 2025 Spike Watch & Capital Protection Trading Alerts - newser.com
ABN Amro Investment Solutions Buys New Position in ResMed Inc. $RMD - MarketBeat
Why ResMed Inc. stock benefits from AI revolutionWeekly Risk Summary & Real-Time Chart Pattern Alerts - newser.com
Can ResMed Inc. (Common Stock) (RMEA) stock attract analyst upgradesBond Market & Long Hold Capital Preservation Tips - newser.com
Will ResMed Inc. (Common Stock) (RMEA) stock see valuation expansionWeekly Trend Recap & Consistent Profit Alerts - newser.com
ResMed (NYSE:RMD) Director Sells $504,100.00 in Stock - MarketBeat
Insider Selling: ResMed (NYSE:RMD) Director Sells $121,871.75 in Stock - MarketBeat
Is ResMed Inc. (RME) stock a buy on weaknessJuly 2025 Retail & Risk Controlled Stock Pick Alerts - newser.com
How ResMed Inc. (Common Stock) (RMEA) stock performs in volatility spikesWeekly Market Outlook & Fast Exit and Entry Trade Guides - newser.com
Is ResMed Inc. stock oversold or undervaluedQuarterly Portfolio Report & Smart Money Movement Alerts - newser.com
Wealth Alliance LLC Invests $309,000 in ResMed Inc. $RMD - MarketBeat
Geode Capital Management LLC Has $1.08 Billion Stock Holdings in ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Shares Purchased by National Pension Service - MarketBeat
How ResMed Inc. (Common Stock) (RMEA) stock reacts to fiscal policiesDollar Strength & AI Based Buy and Sell Signals - newser.com
ResMed Inc. stock falls Friday, underperforms market - MarketWatch
Is ResMed Inc. (RME) stock in buy zone after pullback2025 Sector Review & Precise Swing Trade Alerts - newser.com
Is ResMed Inc. reversing from oversold territoryMarket Activity Recap & Long-Term Growth Portfolio Plans - newser.com
ProShare Advisors LLC Grows Holdings in ResMed Inc. $RMD - MarketBeat
How ResMed Inc. (Common Stock) (RMEA) stock trades after earnings2025 Big Picture & High Return Trade Opportunity Guides - newser.com
Forsta AP Fonden Sells 4,800 Shares of ResMed Inc. $RMD - MarketBeat
ResMed Inc. Reports Changes in Beneficial Ownership - MSN
Resmed Inc Stock (RMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.22%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):